We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.1B
AUM Growth
-$4.09B
Cap. Flow
-$2.77B
Cap. Flow %
-10.63%
Top 10 Hldgs %
22.95%
Holding
1,846
New
56
Increased
388
Reduced
1,301
Closed
96

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$366M
2
MSFT icon
Microsoft
MSFT
+$279M
3
AMZN icon
Amazon
AMZN
+$213M
4
TSLA icon
Tesla
TSLA
+$109M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.74%
2 Consumer Staples 11.79%
3 Consumer Discretionary 11.57%
4 Industrials 10.74%
5 Healthcare 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPI icon
1151
Group 1 Automotive
GPI
$3.94B
$301K ﹤0.01%
2,115
-167
-7% -$28.6K
TNET icon
1152
TriNet
TNET
$2.84B
$301K ﹤0.01%
4,228
-92
-2% -$7.49K
IBTX
1153
DELISTED
Independent Bank Group, Inc.
IBTX
$301K ﹤0.01%
4,911
-260
-5% -$17.9K
AGIO icon
1154
Agios Pharmaceuticals
AGIO
$2.16B
$300K ﹤0.01%
10,629
-677
-6% -$18.2K
BLD
1155
DELISTED
TopBuild
BLD
$300K ﹤0.01%
1,824
-41
-2% -$7.58K
CPRI icon
1156
Capri Holdings
CPRI
$1.77B
$299K ﹤0.01%
7,769
-630
-8% -$29.4K
CNR
1157
Core Natural Resources Inc
CNR
$4.19B
$299K ﹤0.01%
4,676
-99
-2% -$6.27K
INGR icon
1158
Ingredion
INGR
$6.38B
$298K ﹤0.01%
3,686
-82
-2% -$7.2K
TVTX icon
1159
Travere Therapeutics
TVTX
$5.33B
$298K ﹤0.01%
12,094
+306
+3% +$7.91K
AXSM icon
1160
Axsome Therapeutics
AXSM
$12.4B
$297K ﹤0.01%
6,668
+415
+7% +$20.7K
AYI icon
1161
Acuity Brands
AYI
$9.88B
$296K ﹤0.01%
1,878
-126
-6% -$21.3K
SNX icon
1162
TD Synnex
SNX
$19.4B
$295K ﹤0.01%
3,632
-183
-5% -$17.5K
THS
1163
DELISTED
Treehouse Foods
THS
$295K ﹤0.01%
6,981
-340
-5% -$15.2K
WIRE
1164
DELISTED
Encore Wire Corp
WIRE
$295K ﹤0.01%
2,557
-148
-5% -$18K
ZEN
1165
DELISTED
ZENDESK INC
ZEN
$295K ﹤0.01%
3,870
-804
-17% -$61K
CHGG icon
1166
Chegg
CHGG
$108M
$294K ﹤0.01%
13,974
-302
-2% -$6.26K
HRI icon
1167
Herc Holdings
HRI
$5.43B
$294K ﹤0.01%
2,829
-55
-2% -$6.12K
XPO icon
1168
XPO
XPO
$25B
$294K ﹤0.01%
11,113
+1,466
+15% +$45.7K
FVRR icon
1169
Fiverr
FVRR
$376M
$293K ﹤0.01%
9,570
-6,798
-42% -$241K
LYEL icon
1170
Lyell Immunopharma
LYEL
$309M
$293K ﹤0.01%
1,996
+66
+3% +$8.94K
IOSP icon
1171
Innospec
IOSP
$2.09B
$291K ﹤0.01%
3,405
-88
-3% -$8.31K
STNE icon
1172
StoneCo
STNE
$2.62B
$291K ﹤0.01%
30,556
-582
-2% -$5.57K
CALM icon
1173
Cal-Maine
CALM
$4.28B
$290K ﹤0.01%
5,214
-122
-2% -$6.67K
RARE icon
1174
Ultragenyx Pharmaceutical
RARE
$2.65B
$290K ﹤0.01%
7,007
+414
+6% +$21.3K
IOVA icon
1175
Iovance Biotherapeutics
IOVA
$2.23B
$287K ﹤0.01%
29,909
+731
+3% +$8.43K

Similar funds

ProShare Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, ProShare Advisors held 1,846 positions worth $26.1B, down 14% from $30.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

ProShare Advisors withdrew a net $2.77B in Q3 2022, closing 96 positions and reducing 1,301 holdings. Its most notable exit was Neenah, Inc. Common Stock, an estimated $7.52M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, ProShare Advisors opened a new position in Xometry worth $7.31M.

  • ProShare Advisors's largest Q3 2022 buy was Xometry: 128,758 shares worth $7.31M.
  • ProShare Advisors added most to Target in Q3 2022, an estimated $49.4M increase.
  • ProShare Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $366M.
  • ProShare Advisors fully exited Neenah, Inc. Common Stock in Q3 2022, selling an estimated $7.52M.
  • ProShare Advisors's ten largest holdings make up 23% of its $26.1B portfolio in Q3 2022.
  • ProShare Advisors opened 56 new positions and closed 96 in Q3 2022.
  • ProShare Advisors's portfolio value fell 14% quarter-over-quarter to $26.1B.

Based on ProShare Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.